IBD Treatments Don’t Seem to Raise Extracolonic Cancer Risk
Infliximab Use Not Tied to Malignancy in Pediatric IBD
Anti-TNFs in Early Puberty May Improve Growth in Pediatric IBD
FDA Approves Ustekinumab for Crohn’s Disease
Statin Use Tied to Lower Risk of Inflammatory Bowel Disease
Adalimumab & Infliximab Remain in Newborns after Delivery
Biomarkers Differentiate Crohn’s Disease from Ulcerative Colitis
